Jean Claude Habineza

Dr. Jean Claude Habineza

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in JMIR Formative Research
Verified
Journal Article
Open access
JBJason Baker
Jason Baker
Giacomo CapponGiacomo Cappon
Giacomo Cappon
JHJean Claude Habineza
Jean Claude Habineza
CBCorey Basch
Corey Basch
SMSteven Mey
Steven Mey
SNSandhya Narayanan
Sandhya Narayanan
Background: The development of minimally invasive continuous glucose monitoring systems (CGMs) has transformed diabetes management. CGMs have shown clinical significance by improving time in the euglycemic range, decreasing rates of hypoglycemia, and improving hemoglobin A1c (HbA1c). In Rwanda, CGMs are currently not routinely used, and no clinical studies of CGM use were identified in the literature. Objective: This study aims to determine the impact and feasibility of real-time CGM use among people living with type 1 diabetes (T1D) in Rwanda through assessment of sensor use, time in range, rates of hypoglycemia and hyperglycemia, HbA1c, and rates of diabetes-related hospitalizations over time. Methods: The Continuous Glucose Monitoring Among Patients with Type 1 Diabetes in Rwanda (CAPT1D) study is a single-arm, prospective observational study conducted at the Rwandan Diabetes Association clinic in Kigali, Rwanda, aiming to assess the impact and feasibility of CGM use in Rwanda. A cohort of 50 participants diagnosed with T1D were enrolled. Participants were at least 21 years old, undergoing multiple daily insulin therapy, and not currently pregnant. Phase I of the study was conducted over 12 months, using the Dexcom G6 CGM. Phase II and Phase III extended CGM use for an additional 6 months respectively, using the next-generation Dexcom G7 CGM. Here, we report the quantitative results of the Phase I study. Results: Participants used the sensor for >80% of the time throughout the study period. A significant increase in time in range was observed within 3 months and sustained over 12 months. HbA1c decreased significantly in 3 months and stayed lower throughout the 12-month period. Mean HbA1c levels decreased by 2.8% at 6 months (P<.001) and 3.2% at 12 months (P<.001). A total of 12 diabetes-related hospitalizations were reported during the study period. No cases of diabetic ketoacidosis or episodes of severe hypoglycemia occurred. Conclusions: Significant and meaningful improvements in key glycemic indices indicate the potential feasibility and impact of a CGM among people living with T1D in Rwanda. Future studies could be designed to include pre- and postintervention analysis to determine the effectiveness in terms of complications and costs.

10 April 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
NGNshimiyimana Gad
Nshimiyimana Gad
Bakang Percy TlhaloganyangBakang Percy Tlhaloganyang
Bakang Percy Tlhaloganyang
JHJean Claude Habineza
Jean Claude Habineza
NPNiyonsenga Simon Pierre
Niyonsenga Simon Pierre
CMClarisse Musanabaganwa
Clarisse Musanabaganwa
Claude Mambo MuvunyiClaude Mambo Muvunyi
Claude Mambo Muvunyi
Obesity is an emerging public health concern in Rwanda, yet nationally representative data on its associated factors remain limited. This study analyzes recent survey data to assess the prevalence of obesity and explore associated demographic, behavioral, and metabolic characteristics. The study analyzed data from the 2022 Rwanda NCD STEPS Survey, a nationally representative cross-sectional study of 5,509 adults aged 18–69 years. Data collection followed the WHO STEPwise approach and included structured questionnaires, physical measurements, and biochemical tests. Obesity was defined as a body mass index (BMI) ≥30 kg/m 2 . Poisson regression with robust standard errors was used to estimate crude, age- and sex-adjusted, and fully adjusted prevalence ratios (PRs) with 95% confidence intervals (CI) to describe associations between obesity and selected characteristics. The prevalence of obesity in the study population was 4.3% (95% CI: 3.7–5.1%). Obesity was significantly more common among women (APR: 4.2, 95% CI: 2.1–8.5) and adults aged 60–69 years (APR: 2.7, 95% CI: 1.03–6.9) compared to younger adults. Rural residents had a substantially lower prevalence of obesity than urban residents (APR = 0.30, 95% CI: 0.20–0.50). Individuals with primary education (APR: 1.7, 95% CI: 1.02–3.0) were more likely to be obese, while individuals earning less than USD 33/month had lower obesity prevalence (APR: 0.5, 95% CI: 0.2–0.9). Past drinkers (APR: 0.5, 95% CI: 0.3–0.9) and non-heavy drinkers (APR: 0.5, 95% CI: 0.3–0.9) had lower obesity prevalence compared to non-drinkers. Hypertension remained significantly associated with obesity (APR: 1.7, 95% CI: 1.1–2.5). Obesity in Rwanda was significantly associated with sex, age, residence, education, income, alcohol use, and hypertension. Interventions should prioritize older women in urban areas and integrate education-sensitive strategies, alcohol-related risk reduction, and hypertension management into obesity prevention programs.